# ABACAVIR SULFATE AND LAMIVUDINE
> **ANDA216332** · Abbreviated New Drug Application (Generic) · Sponsor: LAURUS · Approved 2022-07-25
## Drug
- **FDA Application Number:** ANDA216332
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ABACAVIR SULFATE AND LAMIVUDINE
- **Generic name:** ABACAVIR AND LAMIVUDINE
- **Active ingredients:** ABACAVIR SULFATE; LAMIVUDINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** LAURUS
- **Manufacturer:** Laurus Labs Limited
- **First approval:** 2022-07-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216332)
---
*AI Analytics · CC0 1.0*